Company Search:
Advanced Search
Sponsored Links
Galapagos NV Company Snapshot
Galapagos NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galapagos NV with three other miscellaneous service companies in Europe: Basilea Pharmaceutica Limited of Switzerland (2015 sales of 51.65 million Swiss Francs [US$52.18 million] of which 100% was Pharmaceutical Products), Cellectis SA of France (56.39 million Euro [US$61.89 million] of which 101% was Therapeutics), and Medivir AB which is based in Sweden (657.89 million Swedish Kronor [US$74.53 million] of which 100% was Pharmaceutical).

Sales Analysis. Galapagos NV reported sales of 60.58 million Euro (US$66.50 million) for the year ending December of 2015. This represents a sharp decrease of 32.7% versus 2014, when the company's sales were 90.02 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Galapagos NV
  Stock Performance Chart for Galapagos NV
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 59.10
(Figures in Euro)
1 Week 2.4%   13 Weeks 9.7%  
4 Weeks 24.4%   52 Weeks 38.2%  
Galapagos NV Key Data:
  Ticker: GLPG Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 60,579,000
(Year Ending Jan 2016).
Employees: 435
  Currency: Euro Market Cap: 2,725,071,923
  Fiscal Yr Ends: December Shares Outstanding: 46,109,508
  Share Type: Action Ordinaries Closely Held Shares: 9,104,986
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.